Rafael Holdings RFL
NYSE RFL
$1.53 +0.03 (+2.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rafael Holdings (RFL) Selling, General & Administrative (2017 - 2026)

Updated

Rafael Holdings (RFL) recorded Selling, General & Administrative of $2.14 million in fiscal Q3 2026 (quarter ended Apr 30, 2026), down 32.5% from $3.17 million a year earlier and down 5.7% from the prior quarter.

Analysis

Rafael Holdings (RFL) Selling, General & Administrative (2017 - 2026) Analysis & Trends

On a TTM basis, Rafael Holdings' Selling, General & Administrative came in at $7.31 million as of Apr 30, 2026, down 31.2% year-over-year; for FY2025 (ended Jul 31, 2025), it was $13.78 million, up 55.6% from FY2024.

  • Annual Selling, General & Administrative has a five-year compound annual growth rate of 8.6% (FY2020 to FY2025).
  • Across earlier fiscal years, Selling, General & Administrative came in at $8.85 million in FY2024 (-0.9%), $8.93 million in FY2023 (-47.4%), $16.98 million in FY2022 (-0.3%) and $17.02 million in FY2021 (+86.7%).
  • Quarterly Selling, General & Administrative has ranged from -$1.68 million in fiscal Q2 2022 to $12.27 million in fiscal Q1 2022 over the past five years.
  • On a year-over-year basis, Selling, General & Administrative rose in five of the last eight quarters, with growth averaging 3.4%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 373.5% in fiscal Q1 2022, against a decline of 97.5% in fiscal Q4 2025 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $2.27 million (Q2 2026), $2.84 million (Q1 2026) and $58,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Rafael Holdings 78.35 Mn 83.76 Mn 163,000.00 2.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 2.14 Mn
Jan 31, 2026 2.27 Mn
Oct 31, 2025 2.84 Mn
Jul 31, 2025 58,000.00
Apr 30, 2025 3.17 Mn
Jan 31, 2025 2.59 Mn
Oct 31, 2024 2.52 Mn
Jul 31, 2024 2.33 Mn
Apr 30, 2024 1.92 Mn
Jan 31, 2024 2.56 Mn
Oct 31, 2023 2.04 Mn
Jul 31, 2023 1.40 Mn
Apr 30, 2023 2.34 Mn
Jan 31, 2023 2.09 Mn
Oct 31, 2022 3.11 Mn
Jul 31, 2022 3.05 Mn
Apr 30, 2022 3.34 Mn
Jan 31, 2022 -1.68 Mn
Oct 31, 2021 12.27 Mn
Jul 31, 2021 8.66 Mn
API Access

Rafael Holdings Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RFL&period=max&api_key=YOUR_API_KEY